公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | Screening therapeutic EMT blocking agents in a three-dimensional microenvironment | Aref A.R.; RUBY YUN-JU HUANG ; Yu W.; Chua K.-N.; Sun W.; Tu T.-Y.; Bai J.; Sim W.-J.; Zervantonakis I.K.; Thiery J.P.; Kamm R.D. | Integrative Biology (United Kingdom) | 139 | 126 | |
2024 | Secretome from Magnetically Stimulated Muscle Exhibits Anticancer Potency: Novel Preconditioning Methodology Highlighting HTRA1 Action | Tai, Yee Kit; Iversen, Jan Nikolas; Chan, Karen Ka Wing; Fong, Charlene Hui Hua; Abdul Razar, Rafhanah Banu; Ramanan, Sharanya; Yap, Lye Yee Jasmine; Yin, Jocelyn Naixin; Toh, Shi Jie; Wong, Craig Jun Kit; Koh, Pei Fern Angele; RUBY YUN-JU HUANG ; Franco-Obregón, Alfredo | Cells | | | |
2007 | Signaling profiles of EGF-induced epithelial-mesenchymal transition of human ovarian surface epithelial cells | RUBY YUN-JU HUANG ; Choi, J. H.; Salamanca, C.; Pelech, S.; Ozbun, L.; Birrer, M.; Auersperg, N. | Annual meeting of the American Association for Cancer Research, proceedings | | | |
2020 | Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity | Ravasio A.; Myaing M.Z.; Chia S.; Arora A.; Sathe A.; Cao E.Y.; Bertocchi C.; Sharma A.; Arasi B.; Chung V.Y.; Green A.C.; Tan T.Z.; Chen Z.; Ong H.T.; Iyer N.G.; RUBY YUN-JU HUANG ; DasGupta R.; Groves J.T.; Viasnoff V. | Communications Biology | 3 | 4 | |
2019 | SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition | Sundararajan V.; Tan M.; Tan T.Z.; Ye J.; Thiery J.P.; RUBY YUN-JU HUANG | Scientific Reports | 30 | 29 | |
2020 | Snai1-driven sequential emt changes attributed by selective chromatin enrichment of RAD21 and GRHL2 | Sundararajan V.; Tan M.; Tan T.Z.; Pang Q.Y.; Ye J.; Chung V.Y.; RUBY YUN-JU HUANG | Cancers | 10 | 11 | |
2014 | A spatiotemporally defined in vitro microenvironment for controllable signal delivery and drug screening | Kuo, C.-T.; Liu, H.-K.; Huang, G.-S.; Chang, C.-H.; Chen, C.-L.; Chen, K.-C.; RUBY YUN-JU HUANG ; CHING-HUNG LIN ; Lee, H.; CHIUN-SHENG HUANG ; ANDREW WO | Analyst | 16 | 14 | |
2020 | Spotlight on the Granules (Grainyhead-Like Proteins) – From an Evolutionary Conserved Controller of Epithelial Trait to Pioneering the Chromatin Landscape | Sundararajan V.; Pang Q.Y.; Choolani M.; RUBY YUN-JU HUANG | Frontiers in Molecular Biosciences | 10 | 9 | |
2020 | Stopping transformed cancer cell growth by rigidity sensing | Yang B.; Wolfenson H.; Chung V.Y.; Nakazawa N.; Liu S.; Hu J.; RUBY YUN-JU HUANG ; Sheetz M.P. | Nature Materials | 65 | 61 | |
2016 | Sustained Gas6/AXL signaling network in the mes subtype of ovarian cancer as a molecular subtype specific therapeutic target | RUBY YUN-JU HUANG ; Antony, J.; Tan, T. Z.; Kelly, Z.; Gabra, H.; Recchi, C.; Thiery, J. P. | Journal of Clinical Oncology | | | |
2017 | Synergistic lethality of mAbs with an EMT reversal agent, Nintedanib, in epithelial ovarian cancer | Teo, J; Tan, HL; RUBY YUN-JU HUANG ; Choo, A | CANCER RESEARCH | 0 | 0 | |
2011 | Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept | Chua K.-N.; Poon K.L.; Lim J.; Sim W.-J.; RUBY YUN-JU HUANG ; Thiery J.P. | Advanced Drug Delivery Reviews | 39 | 37 | |
2012 | Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer | RUBY YUN-JU HUANG ; Chung V.Y.; Thiery J.P. | Current Drug Targets | 66 | 64 | |
2017 | Targeting the AXL signaling pathway in ovarian cancer | RUBY YUN-JU HUANG ; Antony J.; Tan T.Z.; Tan D.S.-P. | Molecular and Cellular Oncology | 13 | 0 | |
2018 | Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis | Shanmugam, Muthu K; Ahn, Kwang Seok; Hsu, Annie; Woo, Chern Chiuh; Yuan, Yi; Tan, Kwong Huat Benny; Chinnathambi, Arunachalam; Alahmadi, Tahani Awad; Alharbi, Sulaiman Ali; Koh, Angele Pei Fern; Arfuso, Frank; RUBY YUN-JU HUANG ; Lim, Lina H K; Sethi, Gautam; Kumar, Alan Prem | Frontiers in pharmacology | 130 | 121 | |
2015 | Transcriptional regulatory loops among SNAI1, TWIST1, ZEB1, and ZEB2 defines the epithelial-mesenchymal transition (EMT) spectrum in epithelial ovarian cancer (EOC) | Tan, M; Chuang, VY; Tan, TZ; Thiery, JP; RUBY YUN-JU HUANG | CANCER RESEARCH | 0 | 0 | |
2010 | Transitions between epithelial and mesenchymal states in microfluidic platform: Acquisition of malignant and stem cell traits | Aref A.R.; RUBY YUN-JU HUANG ; Kang W.; Jing S.W.; Thiery J.P.; Kamm R.D. | Nanotechnology 2010: Electronics, Devices, Fabrication, MEMS, Fluidics and Computational - Technical Proceedings of the 2010 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2010 | 0 | | |
2018 | The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer | Antony J.; Zanini E.; Kelly Z.; Tan T.Z.; Karali E.; Alomary M.; Jung Y.; Nixon K.; Cunnea P.; Fotopoulou C.; Paterson A.; Roy-Nawathe S.; Mills G.B.; RUBY YUN-JU HUANG ; Thiery J.P.; Gabra H.; Recchi C. | EMBO Reports | 26 | 29 | |
2020 | Two high-yield complementary methods to sort cell populations by their 2D or 3D migration speed | Arora A.; Ni?o J.L.G.; Myaing M.Z.; Chia S.; Arasi B.; Ravasio A.; RUBY YUN-JU HUANG ; Dasgupta R.; Biro M.; Viasnoff V. | Molecular Biology of the Cell | 1 | 1 | |
2005 | Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-κB pathway by lysophosphatidic acid, an ovarian cancer-activating factor | Chou C.-H; LING-HUNG WEI ; Kuo M.-L; RUBY YUN-JU HUANG ; Lai K.-P; CHI-AN CHEN ; CHANG-YAO HSIEH | Carcinogenesis | 78 | 74 | |